iSpecimen Inc. (ISPC)
USD 1.25
(-2.34%)
USD 1.25
(-2.34%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 15.81 Million USD | -35.74% |
| 2022 | 24.61 Million USD | -31.08% |
| 2021 | 35.71 Million USD | 475.22% |
| 2020 | 6.2 Million USD | 47.34% |
| 2019 | 4.21 Million USD | 4.2% |
| 2018 | 4.04 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 12.51 Million USD | -20.89% |
| 2024 Q2 | 11.9 Million USD | -4.89% |
| 2023 FY | 15.81 Million USD | -35.74% |
| 2023 Q4 | 15.81 Million USD | -2.92% |
| 2023 Q3 | 16.29 Million USD | -7.26% |
| 2023 Q2 | 17.57 Million USD | -19.91% |
| 2023 Q1 | 21.93 Million USD | -10.88% |
| 2022 Q2 | 30.39 Million USD | -8.68% |
| 2022 Q4 | 24.61 Million USD | -11.89% |
| 2022 Q1 | 33.28 Million USD | -6.81% |
| 2022 FY | 24.61 Million USD | -31.08% |
| 2022 Q3 | 27.93 Million USD | -8.08% |
| 2021 Q2 | 19.6 Million USD | 236.64% |
| 2021 FY | 35.71 Million USD | 475.22% |
| 2021 Q1 | 5.82 Million USD | -6.22% |
| 2021 Q4 | 35.71 Million USD | 102.7% |
| 2021 Q3 | 17.62 Million USD | -10.11% |
| 2020 FY | 6.2 Million USD | 47.34% |
| 2020 Q3 | 6.04 Million USD | 0.0% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q4 | 6.2 Million USD | 2.69% |
| 2019 FY | 4.21 Million USD | 4.2% |
| 2019 Q4 | 4.21 Million USD | 0.0% |
| 2018 FY | 4.04 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 197.4 Million USD | 91.986% |
| Biodesix, Inc. | 99.09 Million USD | 84.037% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -92.411% |
| Castle Biosciences, Inc. | 477.81 Million USD | 96.689% |
| DarioHealth Corp. | 96.38 Million USD | 83.588% |
| Exact Sciences Corporation | 6.47 Billion USD | 99.756% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 99.515% |
| Illumina, Inc. | 10.11 Billion USD | 99.844% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -14.807% |
| Standard BioTools Inc. | 323.06 Million USD | 95.103% |
| 23andMe Holding Co. | 395.16 Million USD | 95.997% |
| Medpace Holdings, Inc. | 1.65 Billion USD | 99.045% |
| NeoGenomics, Inc. | 1.68 Billion USD | 99.059% |
| Inotiv, Inc. | 856.53 Million USD | 98.153% |
| Psychemedics Corporation | 13.27 Million USD | -19.21% |
| Prenetics Global Limited | 254.17 Million USD | 93.776% |
| Precipio, Inc. | 18.1 Million USD | 12.606% |
| RadNet, Inc. | 2.88 Billion USD | 99.452% |
| Sotera Health Company | 3.13 Billion USD | 99.495% |
| Star Equity Holdings, Inc. | 86.97 Million USD | 81.812% |
| Exagen Inc. | 56.94 Million USD | 72.22% |
| Natera, Inc. | 1.45 Billion USD | 98.914% |
| Aspira Women's Health Inc. | 6.26 Million USD | -152.621% |
| Neogen Corporation | 4.58 Billion USD | 99.655% |
| Myriad Genetics, Inc. | 1.19 Billion USD | 98.68% |
| ICON Public Limited Company | 16.98 Billion USD | 99.907% |
| Bionano Genomics, Inc. | 214.4 Million USD | 92.622% |
| CareDx, Inc | 484.61 Million USD | 96.736% |
| Check-Cap Ltd. | 25.01 Million USD | 36.766% |
| Twist Bioscience Corporation | 776.4 Million USD | 97.963% |
| Guardant Health, Inc. | 1.78 Billion USD | 99.114% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -38.767% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | 98.757% |
| Sera Prognostics, Inc. | 95.44 Million USD | 83.425% |
| OPKO Health, Inc. | 2.01 Billion USD | 99.214% |
| Personalis, Inc. | 225.09 Million USD | 92.972% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -15.878% |
| Star Equity Holdings, Inc. | 86.97 Million USD | 81.812% |
| MDxHealth SA | 129.13 Million USD | 87.75% |
| Prenetics Global Limited | 254.17 Million USD | 93.776% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -134.214% |
| Mainz Biomed B.V. | 15.4 Million USD | -2.661% |
| Trinity Biotech plc | 59.43 Million USD | 73.384% |
| Neuronetics, Inc. | 115.83 Million USD | 86.343% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -92.411% |